Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy

The precise delivery of cytotoxic radiation to cancer cells through the combination of a specific targeting vector with a radionuclide for targeted radionuclide therapy (TRT) has proven valuable for cancer care. TRT is increasingly being considered a relevant treatment method in fighting micro-metas...

Full description

Bibliographic Details
Main Authors: Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt, Timo W. M. De Groof, Dora Mugoli Chigoho, Parinaz Asiabi, Peter Covens, Matthias D’Huyvetter, Nick Devoogdt
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceutics
Subjects:
antibody fragments
peptides
radionuclide
radiopharmaceutical
targeted radionuclide therapy
vectors
Online Access:https://www.mdpi.com/1999-4923/15/5/1378

Internet

https://www.mdpi.com/1999-4923/15/5/1378

Similar Items